nodes	percent_of_prediction	percent_of_DWPC	metapath
Furosemide—PGD—Dacarbazine—peripheral nervous system neoplasm	0.476	0.672	CbGbCtD
Furosemide—SLC22A5—Dactinomycin—peripheral nervous system neoplasm	0.0871	0.123	CbGbCtD
Furosemide—ABCC2—Vincristine—peripheral nervous system neoplasm	0.0418	0.0589	CbGbCtD
Furosemide—ABCC2—Cisplatin—peripheral nervous system neoplasm	0.0389	0.055	CbGbCtD
Furosemide—ABCC2—Etoposide—peripheral nervous system neoplasm	0.0383	0.054	CbGbCtD
Furosemide—ABCC2—Doxorubicin—peripheral nervous system neoplasm	0.0261	0.0368	CbGbCtD
Furosemide—Anaphylactic shock—Cisplatin—peripheral nervous system neoplasm	0.000201	0.0007	CcSEcCtD
Furosemide—Anaphylactoid reaction—Doxorubicin—peripheral nervous system neoplasm	0.000201	0.000699	CcSEcCtD
Furosemide—Vomiting—Topotecan—peripheral nervous system neoplasm	0.000199	0.000694	CcSEcCtD
Furosemide—Lethargy—Doxorubicin—peripheral nervous system neoplasm	0.000198	0.00069	CcSEcCtD
Furosemide—Vomiting—Isotretinoin—peripheral nervous system neoplasm	0.000198	0.000689	CcSEcCtD
Furosemide—Vomiting—Tretinoin—peripheral nervous system neoplasm	0.000198	0.000689	CcSEcCtD
Furosemide—Rash—Topotecan—peripheral nervous system neoplasm	0.000198	0.000689	CcSEcCtD
Furosemide—Dermatitis—Topotecan—peripheral nervous system neoplasm	0.000197	0.000688	CcSEcCtD
Furosemide—Decreased appetite—Vincristine—peripheral nervous system neoplasm	0.000197	0.000688	CcSEcCtD
Furosemide—Nervous system disorder—Cisplatin—peripheral nervous system neoplasm	0.000197	0.000686	CcSEcCtD
Furosemide—Thrombocytopenia—Cisplatin—peripheral nervous system neoplasm	0.000197	0.000685	CcSEcCtD
Furosemide—Blood creatinine increased—Epirubicin—peripheral nervous system neoplasm	0.000197	0.000685	CcSEcCtD
Furosemide—Headache—Topotecan—peripheral nervous system neoplasm	0.000196	0.000684	CcSEcCtD
Furosemide—Rash—Tretinoin—peripheral nervous system neoplasm	0.000196	0.000683	CcSEcCtD
Furosemide—Rash—Isotretinoin—peripheral nervous system neoplasm	0.000196	0.000683	CcSEcCtD
Furosemide—Gastrointestinal disorder—Vincristine—peripheral nervous system neoplasm	0.000196	0.000683	CcSEcCtD
Furosemide—Dermatitis—Tretinoin—peripheral nervous system neoplasm	0.000196	0.000682	CcSEcCtD
Furosemide—Dermatitis—Isotretinoin—peripheral nervous system neoplasm	0.000196	0.000682	CcSEcCtD
Furosemide—Fatigue—Vincristine—peripheral nervous system neoplasm	0.000196	0.000682	CcSEcCtD
Furosemide—Vomiting—Melphalan—peripheral nervous system neoplasm	0.000195	0.00068	CcSEcCtD
Furosemide—Dehydration—Epirubicin—peripheral nervous system neoplasm	0.000195	0.00068	CcSEcCtD
Furosemide—Skin disorder—Cisplatin—peripheral nervous system neoplasm	0.000195	0.000679	CcSEcCtD
Furosemide—Hyponatraemia—Doxorubicin—peripheral nervous system neoplasm	0.000195	0.000679	CcSEcCtD
Furosemide—Headache—Tretinoin—peripheral nervous system neoplasm	0.000195	0.000679	CcSEcCtD
Furosemide—Headache—Isotretinoin—peripheral nervous system neoplasm	0.000195	0.000679	CcSEcCtD
Furosemide—Feeling abnormal—Alitretinoin—peripheral nervous system neoplasm	0.000194	0.000677	CcSEcCtD
Furosemide—Pain—Vincristine—peripheral nervous system neoplasm	0.000194	0.000677	CcSEcCtD
Furosemide—Constipation—Vincristine—peripheral nervous system neoplasm	0.000194	0.000677	CcSEcCtD
Furosemide—Hyperhidrosis—Cisplatin—peripheral nervous system neoplasm	0.000194	0.000676	CcSEcCtD
Furosemide—Rash—Melphalan—peripheral nervous system neoplasm	0.000194	0.000674	CcSEcCtD
Furosemide—Dermatitis—Melphalan—peripheral nervous system neoplasm	0.000193	0.000674	CcSEcCtD
Furosemide—Gastrointestinal pain—Alitretinoin—peripheral nervous system neoplasm	0.000193	0.000671	CcSEcCtD
Furosemide—Orthostatic hypotension—Epirubicin—peripheral nervous system neoplasm	0.000192	0.000668	CcSEcCtD
Furosemide—Anorexia—Cisplatin—peripheral nervous system neoplasm	0.000191	0.000667	CcSEcCtD
Furosemide—Hypokalaemia—Epirubicin—peripheral nervous system neoplasm	0.000191	0.000665	CcSEcCtD
Furosemide—Unspecified disorder of skin and subcutaneous tissue—Etoposide—peripheral nervous system neoplasm	0.000191	0.000664	CcSEcCtD
Furosemide—Toxic epidermal necrolysis—Epirubicin—peripheral nervous system neoplasm	0.000189	0.000658	CcSEcCtD
Furosemide—Hypotension—Cisplatin—peripheral nervous system neoplasm	0.000188	0.000654	CcSEcCtD
Furosemide—Hypersensitivity—Dactinomycin—peripheral nervous system neoplasm	0.000187	0.000652	CcSEcCtD
Furosemide—Urticaria—Alitretinoin—peripheral nervous system neoplasm	0.000187	0.000652	CcSEcCtD
Furosemide—Abdominal pain—Alitretinoin—peripheral nervous system neoplasm	0.000186	0.000649	CcSEcCtD
Furosemide—Body temperature increased—Alitretinoin—peripheral nervous system neoplasm	0.000186	0.000649	CcSEcCtD
Furosemide—Nausea—Topotecan—peripheral nervous system neoplasm	0.000186	0.000649	CcSEcCtD
Furosemide—Gastrointestinal pain—Vincristine—peripheral nervous system neoplasm	0.000186	0.000647	CcSEcCtD
Furosemide—Confusional state—Etoposide—peripheral nervous system neoplasm	0.000185	0.000646	CcSEcCtD
Furosemide—Muscular weakness—Epirubicin—peripheral nervous system neoplasm	0.000185	0.000645	CcSEcCtD
Furosemide—Nausea—Isotretinoin—peripheral nervous system neoplasm	0.000185	0.000643	CcSEcCtD
Furosemide—Nausea—Tretinoin—peripheral nervous system neoplasm	0.000185	0.000643	CcSEcCtD
Furosemide—Anaphylactic shock—Etoposide—peripheral nervous system neoplasm	0.000184	0.000641	CcSEcCtD
Furosemide—Abdominal distension—Epirubicin—peripheral nervous system neoplasm	0.000183	0.000636	CcSEcCtD
Furosemide—Asthenia—Dactinomycin—peripheral nervous system neoplasm	0.000182	0.000635	CcSEcCtD
Furosemide—Nausea—Melphalan—peripheral nervous system neoplasm	0.000182	0.000635	CcSEcCtD
Furosemide—Blood creatinine increased—Doxorubicin—peripheral nervous system neoplasm	0.000182	0.000634	CcSEcCtD
Furosemide—Dehydration—Doxorubicin—peripheral nervous system neoplasm	0.000181	0.000629	CcSEcCtD
Furosemide—Paraesthesia—Cisplatin—peripheral nervous system neoplasm	0.00018	0.000628	CcSEcCtD
Furosemide—Thrombocytopenia—Etoposide—peripheral nervous system neoplasm	0.00018	0.000627	CcSEcCtD
Furosemide—Eosinophilia—Epirubicin—peripheral nervous system neoplasm	0.00018	0.000625	CcSEcCtD
Furosemide—Abdominal pain—Vincristine—peripheral nervous system neoplasm	0.000179	0.000625	CcSEcCtD
Furosemide—Body temperature increased—Vincristine—peripheral nervous system neoplasm	0.000179	0.000625	CcSEcCtD
Furosemide—Skin disorder—Etoposide—peripheral nervous system neoplasm	0.000179	0.000622	CcSEcCtD
Furosemide—Hyperhidrosis—Etoposide—peripheral nervous system neoplasm	0.000178	0.00062	CcSEcCtD
Furosemide—Pancreatitis—Epirubicin—peripheral nervous system neoplasm	0.000178	0.000619	CcSEcCtD
Furosemide—Orthostatic hypotension—Doxorubicin—peripheral nervous system neoplasm	0.000177	0.000618	CcSEcCtD
Furosemide—Hypokalaemia—Doxorubicin—peripheral nervous system neoplasm	0.000177	0.000615	CcSEcCtD
Furosemide—Anorexia—Etoposide—peripheral nervous system neoplasm	0.000175	0.000611	CcSEcCtD
Furosemide—Toxic epidermal necrolysis—Doxorubicin—peripheral nervous system neoplasm	0.000175	0.000609	CcSEcCtD
Furosemide—Decreased appetite—Cisplatin—peripheral nervous system neoplasm	0.000175	0.000608	CcSEcCtD
Furosemide—Diarrhoea—Dactinomycin—peripheral nervous system neoplasm	0.000174	0.000606	CcSEcCtD
Furosemide—Hypersensitivity—Alitretinoin—peripheral nervous system neoplasm	0.000174	0.000605	CcSEcCtD
Furosemide—Gastrointestinal disorder—Cisplatin—peripheral nervous system neoplasm	0.000173	0.000604	CcSEcCtD
Furosemide—Hypotension—Etoposide—peripheral nervous system neoplasm	0.000172	0.000599	CcSEcCtD
Furosemide—Pain—Cisplatin—peripheral nervous system neoplasm	0.000172	0.000598	CcSEcCtD
Furosemide—Muscular weakness—Doxorubicin—peripheral nervous system neoplasm	0.000171	0.000596	CcSEcCtD
Furosemide—Asthenia—Alitretinoin—peripheral nervous system neoplasm	0.000169	0.000589	CcSEcCtD
Furosemide—Abdominal distension—Doxorubicin—peripheral nervous system neoplasm	0.000169	0.000588	CcSEcCtD
Furosemide—Pollakiuria—Epirubicin—peripheral nervous system neoplasm	0.000167	0.000584	CcSEcCtD
Furosemide—Hypersensitivity—Vincristine—peripheral nervous system neoplasm	0.000167	0.000583	CcSEcCtD
Furosemide—Pruritus—Alitretinoin—peripheral nervous system neoplasm	0.000167	0.000581	CcSEcCtD
Furosemide—Eosinophilia—Doxorubicin—peripheral nervous system neoplasm	0.000166	0.000579	CcSEcCtD
Furosemide—Photosensitivity reaction—Epirubicin—peripheral nervous system neoplasm	0.000165	0.000577	CcSEcCtD
Furosemide—Feeling abnormal—Cisplatin—peripheral nervous system neoplasm	0.000165	0.000576	CcSEcCtD
Furosemide—Paraesthesia—Etoposide—peripheral nervous system neoplasm	0.000165	0.000575	CcSEcCtD
Furosemide—Pancreatitis—Doxorubicin—peripheral nervous system neoplasm	0.000164	0.000573	CcSEcCtD
Furosemide—Hyperglycaemia—Epirubicin—peripheral nervous system neoplasm	0.000164	0.00057	CcSEcCtD
Furosemide—Somnolence—Etoposide—peripheral nervous system neoplasm	0.000164	0.00057	CcSEcCtD
Furosemide—Asthenia—Vincristine—peripheral nervous system neoplasm	0.000163	0.000568	CcSEcCtD
Furosemide—Drowsiness—Epirubicin—peripheral nervous system neoplasm	0.000162	0.000563	CcSEcCtD
Furosemide—Vomiting—Dactinomycin—peripheral nervous system neoplasm	0.000162	0.000563	CcSEcCtD
Furosemide—Diarrhoea—Alitretinoin—peripheral nervous system neoplasm	0.000161	0.000562	CcSEcCtD
Furosemide—ABCC2—Codeine and Morphine Metabolism—ABCB1—peripheral nervous system neoplasm	0.00016	0.0434	CbGpPWpGaD
Furosemide—Stevens-Johnson syndrome—Epirubicin—peripheral nervous system neoplasm	0.00016	0.000558	CcSEcCtD
Furosemide—Rash—Dactinomycin—peripheral nervous system neoplasm	0.00016	0.000558	CcSEcCtD
Furosemide—Decreased appetite—Etoposide—peripheral nervous system neoplasm	0.00016	0.000557	CcSEcCtD
Furosemide—Renal failure—Epirubicin—peripheral nervous system neoplasm	0.000159	0.000554	CcSEcCtD
Furosemide—Gastrointestinal disorder—Etoposide—peripheral nervous system neoplasm	0.000159	0.000553	CcSEcCtD
Furosemide—Body temperature increased—Cisplatin—peripheral nervous system neoplasm	0.000159	0.000553	CcSEcCtD
Furosemide—Fatigue—Etoposide—peripheral nervous system neoplasm	0.000159	0.000553	CcSEcCtD
Furosemide—Pain—Etoposide—peripheral nervous system neoplasm	0.000157	0.000548	CcSEcCtD
Furosemide—Constipation—Etoposide—peripheral nervous system neoplasm	0.000157	0.000548	CcSEcCtD
Furosemide—Dizziness—Alitretinoin—peripheral nervous system neoplasm	0.000156	0.000543	CcSEcCtD
Furosemide—Diarrhoea—Vincristine—peripheral nervous system neoplasm	0.000155	0.000541	CcSEcCtD
Furosemide—Sweating—Epirubicin—peripheral nervous system neoplasm	0.000155	0.00054	CcSEcCtD
Furosemide—Pollakiuria—Doxorubicin—peripheral nervous system neoplasm	0.000155	0.00054	CcSEcCtD
Furosemide—Photosensitivity reaction—Doxorubicin—peripheral nervous system neoplasm	0.000153	0.000534	CcSEcCtD
Furosemide—Hepatobiliary disease—Epirubicin—peripheral nervous system neoplasm	0.000153	0.000533	CcSEcCtD
Furosemide—Feeling abnormal—Etoposide—peripheral nervous system neoplasm	0.000152	0.000528	CcSEcCtD
Furosemide—Hyperglycaemia—Doxorubicin—peripheral nervous system neoplasm	0.000151	0.000527	CcSEcCtD
Furosemide—Nausea—Dactinomycin—peripheral nervous system neoplasm	0.000151	0.000526	CcSEcCtD
Furosemide—Agranulocytosis—Epirubicin—peripheral nervous system neoplasm	0.000151	0.000526	CcSEcCtD
Furosemide—Gastrointestinal pain—Etoposide—peripheral nervous system neoplasm	0.00015	0.000524	CcSEcCtD
Furosemide—Dizziness—Vincristine—peripheral nervous system neoplasm	0.00015	0.000523	CcSEcCtD
Furosemide—Vomiting—Alitretinoin—peripheral nervous system neoplasm	0.00015	0.000522	CcSEcCtD
Furosemide—Drowsiness—Doxorubicin—peripheral nervous system neoplasm	0.00015	0.000521	CcSEcCtD
Furosemide—Rash—Alitretinoin—peripheral nervous system neoplasm	0.000149	0.000518	CcSEcCtD
Furosemide—Dermatitis—Alitretinoin—peripheral nervous system neoplasm	0.000148	0.000517	CcSEcCtD
Furosemide—Stevens-Johnson syndrome—Doxorubicin—peripheral nervous system neoplasm	0.000148	0.000517	CcSEcCtD
Furosemide—Hypersensitivity—Cisplatin—peripheral nervous system neoplasm	0.000148	0.000515	CcSEcCtD
Furosemide—Headache—Alitretinoin—peripheral nervous system neoplasm	0.000148	0.000514	CcSEcCtD
Furosemide—Renal failure—Doxorubicin—peripheral nervous system neoplasm	0.000147	0.000512	CcSEcCtD
Furosemide—Urticaria—Etoposide—peripheral nervous system neoplasm	0.000146	0.000509	CcSEcCtD
Furosemide—Body temperature increased—Etoposide—peripheral nervous system neoplasm	0.000145	0.000507	CcSEcCtD
Furosemide—Abdominal pain—Etoposide—peripheral nervous system neoplasm	0.000145	0.000507	CcSEcCtD
Furosemide—Vomiting—Vincristine—peripheral nervous system neoplasm	0.000144	0.000503	CcSEcCtD
Furosemide—Asthenia—Cisplatin—peripheral nervous system neoplasm	0.000144	0.000502	CcSEcCtD
Furosemide—Sweating—Doxorubicin—peripheral nervous system neoplasm	0.000143	0.0005	CcSEcCtD
Furosemide—Urinary tract disorder—Epirubicin—peripheral nervous system neoplasm	0.000143	0.000499	CcSEcCtD
Furosemide—Rash—Vincristine—peripheral nervous system neoplasm	0.000143	0.000499	CcSEcCtD
Furosemide—Dermatitis—Vincristine—peripheral nervous system neoplasm	0.000143	0.000498	CcSEcCtD
Furosemide—Urethral disorder—Epirubicin—peripheral nervous system neoplasm	0.000142	0.000496	CcSEcCtD
Furosemide—Headache—Vincristine—peripheral nervous system neoplasm	0.000142	0.000496	CcSEcCtD
Furosemide—Hepatobiliary disease—Doxorubicin—peripheral nervous system neoplasm	0.000141	0.000493	CcSEcCtD
Furosemide—Nausea—Alitretinoin—peripheral nervous system neoplasm	0.00014	0.000488	CcSEcCtD
Furosemide—Visual impairment—Epirubicin—peripheral nervous system neoplasm	0.00014	0.000487	CcSEcCtD
Furosemide—Agranulocytosis—Doxorubicin—peripheral nervous system neoplasm	0.00014	0.000486	CcSEcCtD
Furosemide—Diarrhoea—Cisplatin—peripheral nervous system neoplasm	0.000137	0.000479	CcSEcCtD
Furosemide—Erythema multiforme—Epirubicin—peripheral nervous system neoplasm	0.000137	0.000478	CcSEcCtD
Furosemide—ABCC2—Irinotecan Pathway—BCHE—peripheral nervous system neoplasm	0.000136	0.0369	CbGpPWpGaD
Furosemide—Eye disorder—Epirubicin—peripheral nervous system neoplasm	0.000136	0.000473	CcSEcCtD
Furosemide—Hypersensitivity—Etoposide—peripheral nervous system neoplasm	0.000136	0.000472	CcSEcCtD
Furosemide—Tinnitus—Epirubicin—peripheral nervous system neoplasm	0.000135	0.000471	CcSEcCtD
Furosemide—Nausea—Vincristine—peripheral nervous system neoplasm	0.000135	0.00047	CcSEcCtD
Furosemide—Urinary tract disorder—Doxorubicin—peripheral nervous system neoplasm	0.000133	0.000462	CcSEcCtD
Furosemide—Asthenia—Etoposide—peripheral nervous system neoplasm	0.000132	0.00046	CcSEcCtD
Furosemide—Angiopathy—Epirubicin—peripheral nervous system neoplasm	0.000132	0.000459	CcSEcCtD
Furosemide—Urethral disorder—Doxorubicin—peripheral nervous system neoplasm	0.000132	0.000459	CcSEcCtD
Furosemide—Immune system disorder—Epirubicin—peripheral nervous system neoplasm	0.000131	0.000457	CcSEcCtD
Furosemide—Pruritus—Etoposide—peripheral nervous system neoplasm	0.00013	0.000453	CcSEcCtD
Furosemide—Arrhythmia—Epirubicin—peripheral nervous system neoplasm	0.00013	0.000452	CcSEcCtD
Furosemide—Visual impairment—Doxorubicin—peripheral nervous system neoplasm	0.000129	0.000451	CcSEcCtD
Furosemide—Vomiting—Cisplatin—peripheral nervous system neoplasm	0.000128	0.000445	CcSEcCtD
Furosemide—Erythema multiforme—Doxorubicin—peripheral nervous system neoplasm	0.000127	0.000442	CcSEcCtD
Furosemide—Rash—Cisplatin—peripheral nervous system neoplasm	0.000127	0.000441	CcSEcCtD
Furosemide—Dermatitis—Cisplatin—peripheral nervous system neoplasm	0.000126	0.000441	CcSEcCtD
Furosemide—Malnutrition—Epirubicin—peripheral nervous system neoplasm	0.000126	0.00044	CcSEcCtD
Furosemide—Erythema—Epirubicin—peripheral nervous system neoplasm	0.000126	0.00044	CcSEcCtD
Furosemide—Diarrhoea—Etoposide—peripheral nervous system neoplasm	0.000126	0.000438	CcSEcCtD
Furosemide—Eye disorder—Doxorubicin—peripheral nervous system neoplasm	0.000125	0.000437	CcSEcCtD
Furosemide—Tinnitus—Doxorubicin—peripheral nervous system neoplasm	0.000125	0.000436	CcSEcCtD
Furosemide—Flatulence—Epirubicin—peripheral nervous system neoplasm	0.000124	0.000434	CcSEcCtD
Furosemide—Dysgeusia—Epirubicin—peripheral nervous system neoplasm	0.000124	0.000431	CcSEcCtD
Furosemide—Angiopathy—Doxorubicin—peripheral nervous system neoplasm	0.000122	0.000424	CcSEcCtD
Furosemide—Dizziness—Etoposide—peripheral nervous system neoplasm	0.000122	0.000424	CcSEcCtD
Furosemide—Muscle spasms—Epirubicin—peripheral nervous system neoplasm	0.000121	0.000423	CcSEcCtD
Furosemide—Immune system disorder—Doxorubicin—peripheral nervous system neoplasm	0.000121	0.000423	CcSEcCtD
Furosemide—Arrhythmia—Doxorubicin—peripheral nervous system neoplasm	0.00012	0.000418	CcSEcCtD
Furosemide—Nausea—Cisplatin—peripheral nervous system neoplasm	0.000119	0.000416	CcSEcCtD
Furosemide—Vision blurred—Epirubicin—peripheral nervous system neoplasm	0.000119	0.000415	CcSEcCtD
Furosemide—Vomiting—Etoposide—peripheral nervous system neoplasm	0.000117	0.000407	CcSEcCtD
Furosemide—Malnutrition—Doxorubicin—peripheral nervous system neoplasm	0.000117	0.000407	CcSEcCtD
Furosemide—Erythema—Doxorubicin—peripheral nervous system neoplasm	0.000117	0.000407	CcSEcCtD
Furosemide—Anaemia—Epirubicin—peripheral nervous system neoplasm	0.000117	0.000407	CcSEcCtD
Furosemide—Agitation—Epirubicin—peripheral nervous system neoplasm	0.000116	0.000404	CcSEcCtD
Furosemide—Rash—Etoposide—peripheral nervous system neoplasm	0.000116	0.000404	CcSEcCtD
Furosemide—Dermatitis—Etoposide—peripheral nervous system neoplasm	0.000116	0.000404	CcSEcCtD
Furosemide—Headache—Etoposide—peripheral nervous system neoplasm	0.000115	0.000401	CcSEcCtD
Furosemide—Flatulence—Doxorubicin—peripheral nervous system neoplasm	0.000115	0.000401	CcSEcCtD
Furosemide—Dysgeusia—Doxorubicin—peripheral nervous system neoplasm	0.000114	0.000399	CcSEcCtD
Furosemide—Vertigo—Epirubicin—peripheral nervous system neoplasm	0.000114	0.000395	CcSEcCtD
Furosemide—Leukopenia—Epirubicin—peripheral nervous system neoplasm	0.000113	0.000394	CcSEcCtD
Furosemide—Muscle spasms—Doxorubicin—peripheral nervous system neoplasm	0.000112	0.000392	CcSEcCtD
Furosemide—Vision blurred—Doxorubicin—peripheral nervous system neoplasm	0.00011	0.000384	CcSEcCtD
Furosemide—Nausea—Etoposide—peripheral nervous system neoplasm	0.000109	0.000381	CcSEcCtD
Furosemide—Anaemia—Doxorubicin—peripheral nervous system neoplasm	0.000108	0.000376	CcSEcCtD
Furosemide—Agitation—Doxorubicin—peripheral nervous system neoplasm	0.000107	0.000374	CcSEcCtD
Furosemide—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—peripheral nervous system neoplasm	0.000107	0.000372	CcSEcCtD
Furosemide—Dry mouth—Epirubicin—peripheral nervous system neoplasm	0.000105	0.000366	CcSEcCtD
Furosemide—Vertigo—Doxorubicin—peripheral nervous system neoplasm	0.000105	0.000366	CcSEcCtD
Furosemide—Leukopenia—Doxorubicin—peripheral nervous system neoplasm	0.000105	0.000365	CcSEcCtD
Furosemide—Confusional state—Epirubicin—peripheral nervous system neoplasm	0.000104	0.000362	CcSEcCtD
Furosemide—Anaphylactic shock—Epirubicin—peripheral nervous system neoplasm	0.000103	0.000359	CcSEcCtD
Furosemide—Shock—Epirubicin—peripheral nervous system neoplasm	0.000101	0.000353	CcSEcCtD
Furosemide—Nervous system disorder—Epirubicin—peripheral nervous system neoplasm	0.000101	0.000352	CcSEcCtD
Furosemide—Thrombocytopenia—Epirubicin—peripheral nervous system neoplasm	0.000101	0.000352	CcSEcCtD
Furosemide—Skin disorder—Epirubicin—peripheral nervous system neoplasm	0.0001	0.000349	CcSEcCtD
Furosemide—Hyperhidrosis—Epirubicin—peripheral nervous system neoplasm	9.97e-05	0.000347	CcSEcCtD
Furosemide—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—peripheral nervous system neoplasm	9.88e-05	0.000344	CcSEcCtD
Furosemide—Anorexia—Epirubicin—peripheral nervous system neoplasm	9.83e-05	0.000342	CcSEcCtD
Furosemide—Dry mouth—Doxorubicin—peripheral nervous system neoplasm	9.73e-05	0.000339	CcSEcCtD
Furosemide—Hypotension—Epirubicin—peripheral nervous system neoplasm	9.63e-05	0.000336	CcSEcCtD
Furosemide—Confusional state—Doxorubicin—peripheral nervous system neoplasm	9.62e-05	0.000335	CcSEcCtD
Furosemide—Anaphylactic shock—Doxorubicin—peripheral nervous system neoplasm	9.54e-05	0.000332	CcSEcCtD
Furosemide—Shock—Doxorubicin—peripheral nervous system neoplasm	9.39e-05	0.000327	CcSEcCtD
Furosemide—Nervous system disorder—Doxorubicin—peripheral nervous system neoplasm	9.36e-05	0.000326	CcSEcCtD
Furosemide—Thrombocytopenia—Doxorubicin—peripheral nervous system neoplasm	9.34e-05	0.000325	CcSEcCtD
Furosemide—Skin disorder—Doxorubicin—peripheral nervous system neoplasm	9.27e-05	0.000323	CcSEcCtD
Furosemide—Paraesthesia—Epirubicin—peripheral nervous system neoplasm	9.26e-05	0.000323	CcSEcCtD
Furosemide—Hyperhidrosis—Doxorubicin—peripheral nervous system neoplasm	9.22e-05	0.000321	CcSEcCtD
Furosemide—Somnolence—Epirubicin—peripheral nervous system neoplasm	9.17e-05	0.000319	CcSEcCtD
Furosemide—Anorexia—Doxorubicin—peripheral nervous system neoplasm	9.09e-05	0.000317	CcSEcCtD
Furosemide—CA1—C-MYB transcription factor network—CD34—peripheral nervous system neoplasm	9.01e-05	0.0244	CbGpPWpGaD
Furosemide—Decreased appetite—Epirubicin—peripheral nervous system neoplasm	8.96e-05	0.000312	CcSEcCtD
Furosemide—Hypotension—Doxorubicin—peripheral nervous system neoplasm	8.91e-05	0.000311	CcSEcCtD
Furosemide—Gastrointestinal disorder—Epirubicin—peripheral nervous system neoplasm	8.9e-05	0.00031	CcSEcCtD
Furosemide—Fatigue—Epirubicin—peripheral nervous system neoplasm	8.89e-05	0.00031	CcSEcCtD
Furosemide—Pain—Epirubicin—peripheral nervous system neoplasm	8.82e-05	0.000307	CcSEcCtD
Furosemide—Constipation—Epirubicin—peripheral nervous system neoplasm	8.82e-05	0.000307	CcSEcCtD
Furosemide—ABCC2—Drug Induction of Bile Acid Pathway—ABCB1—peripheral nervous system neoplasm	8.77e-05	0.0238	CbGpPWpGaD
Furosemide—Paraesthesia—Doxorubicin—peripheral nervous system neoplasm	8.57e-05	0.000298	CcSEcCtD
Furosemide—Feeling abnormal—Epirubicin—peripheral nervous system neoplasm	8.5e-05	0.000296	CcSEcCtD
Furosemide—Somnolence—Doxorubicin—peripheral nervous system neoplasm	8.48e-05	0.000295	CcSEcCtD
Furosemide—Gastrointestinal pain—Epirubicin—peripheral nervous system neoplasm	8.43e-05	0.000294	CcSEcCtD
Furosemide—Decreased appetite—Doxorubicin—peripheral nervous system neoplasm	8.29e-05	0.000289	CcSEcCtD
Furosemide—Gastrointestinal disorder—Doxorubicin—peripheral nervous system neoplasm	8.24e-05	0.000287	CcSEcCtD
Furosemide—Fatigue—Doxorubicin—peripheral nervous system neoplasm	8.23e-05	0.000287	CcSEcCtD
Furosemide—Urticaria—Epirubicin—peripheral nervous system neoplasm	8.19e-05	0.000285	CcSEcCtD
Furosemide—Constipation—Doxorubicin—peripheral nervous system neoplasm	8.16e-05	0.000284	CcSEcCtD
Furosemide—Pain—Doxorubicin—peripheral nervous system neoplasm	8.16e-05	0.000284	CcSEcCtD
Furosemide—Abdominal pain—Epirubicin—peripheral nervous system neoplasm	8.15e-05	0.000284	CcSEcCtD
Furosemide—Body temperature increased—Epirubicin—peripheral nervous system neoplasm	8.15e-05	0.000284	CcSEcCtD
Furosemide—SLC12A1—ganglion—peripheral nervous system neoplasm	8.05e-05	0.123	CbGeAlD
Furosemide—Feeling abnormal—Doxorubicin—peripheral nervous system neoplasm	7.86e-05	0.000274	CcSEcCtD
Furosemide—Gastrointestinal pain—Doxorubicin—peripheral nervous system neoplasm	7.8e-05	0.000272	CcSEcCtD
Furosemide—PGD—Carbohydrate metabolism—GNS—peripheral nervous system neoplasm	7.67e-05	0.0208	CbGpPWpGaD
Furosemide—Hypersensitivity—Epirubicin—peripheral nervous system neoplasm	7.6e-05	0.000265	CcSEcCtD
Furosemide—Urticaria—Doxorubicin—peripheral nervous system neoplasm	7.58e-05	0.000264	CcSEcCtD
Furosemide—Body temperature increased—Doxorubicin—peripheral nervous system neoplasm	7.54e-05	0.000263	CcSEcCtD
Furosemide—Abdominal pain—Doxorubicin—peripheral nervous system neoplasm	7.54e-05	0.000263	CcSEcCtD
Furosemide—Asthenia—Epirubicin—peripheral nervous system neoplasm	7.4e-05	0.000258	CcSEcCtD
Furosemide—Pruritus—Epirubicin—peripheral nervous system neoplasm	7.29e-05	0.000254	CcSEcCtD
Furosemide—Diarrhoea—Epirubicin—peripheral nervous system neoplasm	7.05e-05	0.000246	CcSEcCtD
Furosemide—Hypersensitivity—Doxorubicin—peripheral nervous system neoplasm	7.03e-05	0.000245	CcSEcCtD
Furosemide—Asthenia—Doxorubicin—peripheral nervous system neoplasm	6.84e-05	0.000238	CcSEcCtD
Furosemide—Dizziness—Epirubicin—peripheral nervous system neoplasm	6.82e-05	0.000238	CcSEcCtD
Furosemide—Pruritus—Doxorubicin—peripheral nervous system neoplasm	6.75e-05	0.000235	CcSEcCtD
Furosemide—Vomiting—Epirubicin—peripheral nervous system neoplasm	6.56e-05	0.000228	CcSEcCtD
Furosemide—Diarrhoea—Doxorubicin—peripheral nervous system neoplasm	6.53e-05	0.000227	CcSEcCtD
Furosemide—Rash—Epirubicin—peripheral nervous system neoplasm	6.5e-05	0.000227	CcSEcCtD
Furosemide—Dermatitis—Epirubicin—peripheral nervous system neoplasm	6.49e-05	0.000226	CcSEcCtD
Furosemide—CA9—HIF-1-alpha transcription factor network—SLC2A1—peripheral nervous system neoplasm	6.46e-05	0.0175	CbGpPWpGaD
Furosemide—Headache—Epirubicin—peripheral nervous system neoplasm	6.46e-05	0.000225	CcSEcCtD
Furosemide—Dizziness—Doxorubicin—peripheral nervous system neoplasm	6.31e-05	0.00022	CcSEcCtD
Furosemide—Nausea—Epirubicin—peripheral nervous system neoplasm	6.12e-05	0.000213	CcSEcCtD
Furosemide—Vomiting—Doxorubicin—peripheral nervous system neoplasm	6.07e-05	0.000211	CcSEcCtD
Furosemide—CA9—Cellular responses to stress—EED—peripheral nervous system neoplasm	6.04e-05	0.0164	CbGpPWpGaD
Furosemide—Rash—Doxorubicin—peripheral nervous system neoplasm	6.02e-05	0.00021	CcSEcCtD
Furosemide—Dermatitis—Doxorubicin—peripheral nervous system neoplasm	6.01e-05	0.000209	CcSEcCtD
Furosemide—Headache—Doxorubicin—peripheral nervous system neoplasm	5.98e-05	0.000208	CcSEcCtD
Furosemide—PGD—NRF2 pathway—SLC2A1—peripheral nervous system neoplasm	5.93e-05	0.0161	CbGpPWpGaD
Furosemide—Nausea—Doxorubicin—peripheral nervous system neoplasm	5.67e-05	0.000197	CcSEcCtD
Furosemide—CA1—nerve—peripheral nervous system neoplasm	5.61e-05	0.0859	CbGeAlD
Furosemide—ABCC2—Constitutive Androstane Receptor Pathway—ABCB1—peripheral nervous system neoplasm	5.29e-05	0.0143	CbGpPWpGaD
Furosemide—CA9—HIF-1-alpha transcription factor network—ABCB1—peripheral nervous system neoplasm	5.1e-05	0.0138	CbGpPWpGaD
Furosemide—ABCC2—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—peripheral nervous system neoplasm	5.04e-05	0.0137	CbGpPWpGaD
Furosemide—CA6—parotid gland—peripheral nervous system neoplasm	4.83e-05	0.074	CbGeAlD
Furosemide—CA9—Cellular responses to stress—SUZ12—peripheral nervous system neoplasm	4.83e-05	0.0131	CbGpPWpGaD
Furosemide—ABCC2—ABC-family proteins mediated transport—ABCB1—peripheral nervous system neoplasm	4.81e-05	0.013	CbGpPWpGaD
Furosemide—PGD—Carbohydrate metabolism—ENO2—peripheral nervous system neoplasm	4.65e-05	0.0126	CbGpPWpGaD
Furosemide—PGD—NRF2 pathway—HGF—peripheral nervous system neoplasm	4.54e-05	0.0123	CbGpPWpGaD
Furosemide—CA4—nerve—peripheral nervous system neoplasm	4.38e-05	0.0671	CbGeAlD
Furosemide—CA4—ganglion—peripheral nervous system neoplasm	4.33e-05	0.0663	CbGeAlD
Furosemide—ALB—FOXA2 and FOXA3 transcription factor networks—NF1—peripheral nervous system neoplasm	4.15e-05	0.0112	CbGpPWpGaD
Furosemide—SLCO2A1—SLC-mediated transmembrane transport—SLC2A1—peripheral nervous system neoplasm	4.08e-05	0.0111	CbGpPWpGaD
Furosemide—CA14—Metabolism—PPIP5K2—peripheral nervous system neoplasm	3.96e-05	0.0107	CbGpPWpGaD
Furosemide—SLCO2A1—Transmembrane transport of small molecules—COX2—peripheral nervous system neoplasm	3.92e-05	0.0106	CbGpPWpGaD
Furosemide—CA6—Metabolism—PPIP5K2—peripheral nervous system neoplasm	3.86e-05	0.0105	CbGpPWpGaD
Furosemide—CA5A—Metabolism—PPIP5K2—peripheral nervous system neoplasm	3.86e-05	0.0105	CbGpPWpGaD
Furosemide—PGD—Carbohydrate metabolism—SLC2A1—peripheral nervous system neoplasm	3.75e-05	0.0101	CbGpPWpGaD
Furosemide—PGD—Metabolism—PPIP5K2—peripheral nervous system neoplasm	3.73e-05	0.0101	CbGpPWpGaD
Furosemide—SLCO2A1—trigeminal ganglion—peripheral nervous system neoplasm	3.65e-05	0.0559	CbGeAlD
Furosemide—CA5B—Metabolism—PPIP5K2—peripheral nervous system neoplasm	3.61e-05	0.00977	CbGpPWpGaD
Furosemide—CA7—Metabolism—PPIP5K2—peripheral nervous system neoplasm	3.61e-05	0.00977	CbGpPWpGaD
Furosemide—SLCO2A1—parotid gland—peripheral nervous system neoplasm	3.44e-05	0.0527	CbGeAlD
Furosemide—SLC12A1—SLC-mediated transmembrane transport—SLC2A1—peripheral nervous system neoplasm	3.41e-05	0.00923	CbGpPWpGaD
Furosemide—CA12—Metabolism—PPIP5K2—peripheral nervous system neoplasm	3.34e-05	0.00905	CbGpPWpGaD
Furosemide—SLC12A1—Transmembrane transport of small molecules—COX2—peripheral nervous system neoplasm	3.27e-05	0.00887	CbGpPWpGaD
Furosemide—PGD—trigeminal ganglion—peripheral nervous system neoplasm	3.25e-05	0.0498	CbGeAlD
Furosemide—PGD—parotid gland—peripheral nervous system neoplasm	3.07e-05	0.047	CbGeAlD
Furosemide—CA1—C-MYB transcription factor network—CDKN2A—peripheral nervous system neoplasm	2.8e-05	0.00759	CbGpPWpGaD
Furosemide—CA14—Metabolism—HSD17B12—peripheral nervous system neoplasm	2.68e-05	0.00725	CbGpPWpGaD
Furosemide—CA4—Metabolism—PPIP5K2—peripheral nervous system neoplasm	2.66e-05	0.00722	CbGpPWpGaD
Furosemide—CA5A—Metabolism—HSD17B12—peripheral nervous system neoplasm	2.61e-05	0.00707	CbGpPWpGaD
Furosemide—CA6—Metabolism—HSD17B12—peripheral nervous system neoplasm	2.61e-05	0.00707	CbGpPWpGaD
Furosemide—CA2—Metabolism—PPIP5K2—peripheral nervous system neoplasm	2.55e-05	0.00692	CbGpPWpGaD
Furosemide—PGD—Metabolism—HSD17B12—peripheral nervous system neoplasm	2.52e-05	0.00682	CbGpPWpGaD
Furosemide—CA1—Metabolism—PPIP5K2—peripheral nervous system neoplasm	2.45e-05	0.00664	CbGpPWpGaD
Furosemide—CA5B—Metabolism—HSD17B12—peripheral nervous system neoplasm	2.44e-05	0.0066	CbGpPWpGaD
Furosemide—CA7—Metabolism—HSD17B12—peripheral nervous system neoplasm	2.44e-05	0.0066	CbGpPWpGaD
Furosemide—CA7—cerebellum—peripheral nervous system neoplasm	2.31e-05	0.0353	CbGeAlD
Furosemide—SLC22A8—trigeminal ganglion—peripheral nervous system neoplasm	2.29e-05	0.0352	CbGeAlD
Furosemide—CA12—Metabolism—HSD17B12—peripheral nervous system neoplasm	2.26e-05	0.00611	CbGpPWpGaD
Furosemide—PGD—Disease—GNS—peripheral nervous system neoplasm	2.17e-05	0.00589	CbGpPWpGaD
Furosemide—CA9—Metabolism—PPIP5K2—peripheral nervous system neoplasm	2.15e-05	0.00583	CbGpPWpGaD
Furosemide—CA9—Cellular responses to stress—IFNB1—peripheral nervous system neoplasm	2.12e-05	0.00573	CbGpPWpGaD
Furosemide—SLCO2A1—Transmembrane transport of small molecules—SLC2A1—peripheral nervous system neoplasm	2.07e-05	0.00562	CbGpPWpGaD
Furosemide—CA1—C-MYB transcription factor network—NRAS—peripheral nervous system neoplasm	2.04e-05	0.00552	CbGpPWpGaD
Furosemide—SLC22A11—SLC-mediated transmembrane transport—SLC2A1—peripheral nervous system neoplasm	2.03e-05	0.00551	CbGpPWpGaD
Furosemide—CA9—cerebellum—peripheral nervous system neoplasm	2.03e-05	0.031	CbGeAlD
Furosemide—CA4—parotid gland—peripheral nervous system neoplasm	2.01e-05	0.0307	CbGeAlD
Furosemide—ABCC2—NRF2 pathway—SLC2A1—peripheral nervous system neoplasm	1.99e-05	0.00539	CbGpPWpGaD
Furosemide—SLC22A11—Transmembrane transport of small molecules—COX2—peripheral nervous system neoplasm	1.95e-05	0.00529	CbGpPWpGaD
Furosemide—CA14—Metabolism—GNS—peripheral nervous system neoplasm	1.94e-05	0.00524	CbGpPWpGaD
Furosemide—CA14—cerebellum—peripheral nervous system neoplasm	1.92e-05	0.0294	CbGeAlD
Furosemide—CA1—C-MYB transcription factor network—MYC—peripheral nervous system neoplasm	1.9e-05	0.00514	CbGpPWpGaD
Furosemide—CA5A—Metabolism—GNS—peripheral nervous system neoplasm	1.89e-05	0.00511	CbGpPWpGaD
Furosemide—CA6—Metabolism—GNS—peripheral nervous system neoplasm	1.89e-05	0.00511	CbGpPWpGaD
Furosemide—CA4—brainstem—peripheral nervous system neoplasm	1.88e-05	0.0288	CbGeAlD
Furosemide—CA14—Metabolism—NME1—peripheral nervous system neoplasm	1.86e-05	0.00503	CbGpPWpGaD
Furosemide—PGD—Metabolism—GNS—peripheral nervous system neoplasm	1.82e-05	0.00493	CbGpPWpGaD
Furosemide—CA6—Metabolism—NME1—peripheral nervous system neoplasm	1.81e-05	0.0049	CbGpPWpGaD
Furosemide—CA5A—Metabolism—NME1—peripheral nervous system neoplasm	1.81e-05	0.0049	CbGpPWpGaD
Furosemide—CA4—Metabolism—HSD17B12—peripheral nervous system neoplasm	1.8e-05	0.00488	CbGpPWpGaD
Furosemide—CA14—Metabolism—COX2—peripheral nervous system neoplasm	1.79e-05	0.00484	CbGpPWpGaD
Furosemide—CA2—trigeminal ganglion—peripheral nervous system neoplasm	1.76e-05	0.027	CbGeAlD
Furosemide—CA7—Metabolism—GNS—peripheral nervous system neoplasm	1.76e-05	0.00477	CbGpPWpGaD
Furosemide—CA5B—Metabolism—GNS—peripheral nervous system neoplasm	1.76e-05	0.00477	CbGpPWpGaD
Furosemide—PGD—Metabolism—NME1—peripheral nervous system neoplasm	1.74e-05	0.00473	CbGpPWpGaD
Furosemide—CA5A—Metabolism—COX2—peripheral nervous system neoplasm	1.74e-05	0.00472	CbGpPWpGaD
Furosemide—CA6—Metabolism—COX2—peripheral nervous system neoplasm	1.74e-05	0.00472	CbGpPWpGaD
Furosemide—SLC22A5—trigeminal ganglion—peripheral nervous system neoplasm	1.73e-05	0.0266	CbGeAlD
Furosemide—SLC12A1—Transmembrane transport of small molecules—SLC2A1—peripheral nervous system neoplasm	1.73e-05	0.00469	CbGpPWpGaD
Furosemide—CA2—Metabolism—HSD17B12—peripheral nervous system neoplasm	1.73e-05	0.00467	CbGpPWpGaD
Furosemide—SLC22A5—SLC-mediated transmembrane transport—SLC2A1—peripheral nervous system neoplasm	1.71e-05	0.00465	CbGpPWpGaD
Furosemide—CA7—Metabolism—NME1—peripheral nervous system neoplasm	1.69e-05	0.00457	CbGpPWpGaD
Furosemide—CA5B—Metabolism—NME1—peripheral nervous system neoplasm	1.69e-05	0.00457	CbGpPWpGaD
Furosemide—PGD—Metabolism—COX2—peripheral nervous system neoplasm	1.68e-05	0.00455	CbGpPWpGaD
Furosemide—SLCO2A1—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	1.67e-05	0.00452	CbGpPWpGaD
Furosemide—CA2—parotid gland—peripheral nervous system neoplasm	1.66e-05	0.0255	CbGeAlD
Furosemide—CA1—Metabolism—HSD17B12—peripheral nervous system neoplasm	1.65e-05	0.00448	CbGpPWpGaD
Furosemide—SLC22A5—Transmembrane transport of small molecules—COX2—peripheral nervous system neoplasm	1.65e-05	0.00446	CbGpPWpGaD
Furosemide—SLCO2A1—Transmembrane transport of small molecules—ABCB1—peripheral nervous system neoplasm	1.64e-05	0.00444	CbGpPWpGaD
Furosemide—SLC22A5—parotid gland—peripheral nervous system neoplasm	1.64e-05	0.0251	CbGeAlD
Furosemide—CA12—Metabolism—GNS—peripheral nervous system neoplasm	1.63e-05	0.00442	CbGpPWpGaD
Furosemide—CA5B—Metabolism—COX2—peripheral nervous system neoplasm	1.63e-05	0.0044	CbGpPWpGaD
Furosemide—CA7—Metabolism—COX2—peripheral nervous system neoplasm	1.63e-05	0.0044	CbGpPWpGaD
Furosemide—ALB—Platelet degranulation—KNG1—peripheral nervous system neoplasm	1.59e-05	0.00431	CbGpPWpGaD
Furosemide—CA12—Metabolism—NME1—peripheral nervous system neoplasm	1.56e-05	0.00424	CbGpPWpGaD
Furosemide—CA2—brainstem—peripheral nervous system neoplasm	1.56e-05	0.0239	CbGeAlD
Furosemide—SLC22A8—SLC-mediated transmembrane transport—SLC2A1—peripheral nervous system neoplasm	1.55e-05	0.0042	CbGpPWpGaD
Furosemide—ABCC2—NRF2 pathway—HGF—peripheral nervous system neoplasm	1.52e-05	0.00413	CbGpPWpGaD
Furosemide—PGD—Disease—PPP3R1—peripheral nervous system neoplasm	1.52e-05	0.00412	CbGpPWpGaD
Furosemide—ALB—Response to elevated platelet cytosolic Ca2+—KNG1—peripheral nervous system neoplasm	1.51e-05	0.0041	CbGpPWpGaD
Furosemide—CA12—Metabolism—COX2—peripheral nervous system neoplasm	1.51e-05	0.00408	CbGpPWpGaD
Furosemide—CA1—C-MYB transcription factor network—HRAS—peripheral nervous system neoplasm	1.49e-05	0.00404	CbGpPWpGaD
Furosemide—SLC22A8—Transmembrane transport of small molecules—COX2—peripheral nervous system neoplasm	1.49e-05	0.00403	CbGpPWpGaD
Furosemide—CA9—Metabolism—HSD17B12—peripheral nervous system neoplasm	1.45e-05	0.00394	CbGpPWpGaD
Furosemide—PGD—cerebellum—peripheral nervous system neoplasm	1.42e-05	0.0217	CbGeAlD
Furosemide—CA9—HIF-1-alpha transcription factor network—AKT1—peripheral nervous system neoplasm	1.4e-05	0.0038	CbGpPWpGaD
Furosemide—SLC12A1—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	1.39e-05	0.00378	CbGpPWpGaD
Furosemide—SLC12A1—Transmembrane transport of small molecules—ABCB1—peripheral nervous system neoplasm	1.37e-05	0.0037	CbGpPWpGaD
Furosemide—ALB—Platelet degranulation—HGF—peripheral nervous system neoplasm	1.32e-05	0.00359	CbGpPWpGaD
Furosemide—PGD—Disease—ENO2—peripheral nervous system neoplasm	1.32e-05	0.00357	CbGpPWpGaD
Furosemide—CA4—Metabolism—GNS—peripheral nervous system neoplasm	1.3e-05	0.00353	CbGpPWpGaD
Furosemide—SLC22A6—SLC-mediated transmembrane transport—SLC2A1—peripheral nervous system neoplasm	1.29e-05	0.00351	CbGpPWpGaD
Furosemide—ALB—Response to elevated platelet cytosolic Ca2+—HGF—peripheral nervous system neoplasm	1.26e-05	0.00342	CbGpPWpGaD
Furosemide—CA4—Metabolism—NME1—peripheral nervous system neoplasm	1.25e-05	0.00338	CbGpPWpGaD
Furosemide—CA2—Metabolism—GNS—peripheral nervous system neoplasm	1.25e-05	0.00338	CbGpPWpGaD
Furosemide—SLC22A6—Transmembrane transport of small molecules—COX2—peripheral nervous system neoplasm	1.24e-05	0.00337	CbGpPWpGaD
Furosemide—ABCC2—Transmembrane transport of small molecules—COX2—peripheral nervous system neoplasm	1.2e-05	0.00326	CbGpPWpGaD
Furosemide—CA4—Metabolism—COX2—peripheral nervous system neoplasm	1.2e-05	0.00325	CbGpPWpGaD
Furosemide—CA1—Metabolism—GNS—peripheral nervous system neoplasm	1.2e-05	0.00324	CbGpPWpGaD
Furosemide—CA2—Metabolism—NME1—peripheral nervous system neoplasm	1.2e-05	0.00324	CbGpPWpGaD
Furosemide—CA14—Metabolism—ENO2—peripheral nervous system neoplasm	1.17e-05	0.00318	CbGpPWpGaD
Furosemide—CA2—Metabolism—COX2—peripheral nervous system neoplasm	1.15e-05	0.00312	CbGpPWpGaD
Furosemide—CA1—Metabolism—NME1—peripheral nervous system neoplasm	1.15e-05	0.00311	CbGpPWpGaD
Furosemide—CA6—Metabolism—ENO2—peripheral nervous system neoplasm	1.14e-05	0.0031	CbGpPWpGaD
Furosemide—CA5A—Metabolism—ENO2—peripheral nervous system neoplasm	1.14e-05	0.0031	CbGpPWpGaD
Furosemide—CA1—Metabolism—COX2—peripheral nervous system neoplasm	1.1e-05	0.00299	CbGpPWpGaD
Furosemide—PGD—Metabolism—ENO2—peripheral nervous system neoplasm	1.1e-05	0.00299	CbGpPWpGaD
Furosemide—CA5B—Metabolism—ENO2—peripheral nervous system neoplasm	1.07e-05	0.00289	CbGpPWpGaD
Furosemide—CA7—Metabolism—ENO2—peripheral nervous system neoplasm	1.07e-05	0.00289	CbGpPWpGaD
Furosemide—PGD—Disease—SLC2A1—peripheral nervous system neoplasm	1.06e-05	0.00288	CbGpPWpGaD
Furosemide—CA9—Metabolism—GNS—peripheral nervous system neoplasm	1.05e-05	0.00285	CbGpPWpGaD
Furosemide—SLC22A11—Transmembrane transport of small molecules—SLC2A1—peripheral nervous system neoplasm	1.03e-05	0.0028	CbGpPWpGaD
Furosemide—ALB—Metabolism of lipids and lipoproteins—HSD17B12—peripheral nervous system neoplasm	1.02e-05	0.00276	CbGpPWpGaD
Furosemide—CA9—Metabolism—NME1—peripheral nervous system neoplasm	1.01e-05	0.00273	CbGpPWpGaD
Furosemide—CA14—Metabolism—BCHE—peripheral nervous system neoplasm	9.91e-06	0.00268	CbGpPWpGaD
Furosemide—CA12—Metabolism—ENO2—peripheral nervous system neoplasm	9.88e-06	0.00268	CbGpPWpGaD
Furosemide—CA9—Cellular responses to stress—CDKN2A—peripheral nervous system neoplasm	9.85e-06	0.00267	CbGpPWpGaD
Furosemide—CA9—Metabolism—COX2—peripheral nervous system neoplasm	9.7e-06	0.00263	CbGpPWpGaD
Furosemide—CA6—Metabolism—BCHE—peripheral nervous system neoplasm	9.66e-06	0.00262	CbGpPWpGaD
Furosemide—CA5A—Metabolism—BCHE—peripheral nervous system neoplasm	9.66e-06	0.00262	CbGpPWpGaD
Furosemide—CA14—Metabolism—SLC2A1—peripheral nervous system neoplasm	9.45e-06	0.00256	CbGpPWpGaD
Furosemide—PGD—Metabolism—BCHE—peripheral nervous system neoplasm	9.32e-06	0.00252	CbGpPWpGaD
Furosemide—CA14—Metabolism—TH—peripheral nervous system neoplasm	9.32e-06	0.00252	CbGpPWpGaD
Furosemide—CA4—cerebellum—peripheral nervous system neoplasm	9.28e-06	0.0142	CbGeAlD
Furosemide—CA5A—Metabolism—SLC2A1—peripheral nervous system neoplasm	9.21e-06	0.0025	CbGpPWpGaD
Furosemide—CA6—Metabolism—SLC2A1—peripheral nervous system neoplasm	9.21e-06	0.0025	CbGpPWpGaD
Furosemide—CA5A—Metabolism—TH—peripheral nervous system neoplasm	9.08e-06	0.00246	CbGpPWpGaD
Furosemide—CA6—Metabolism—TH—peripheral nervous system neoplasm	9.08e-06	0.00246	CbGpPWpGaD
Furosemide—CA5B—Metabolism—BCHE—peripheral nervous system neoplasm	9.02e-06	0.00244	CbGpPWpGaD
Furosemide—CA7—Metabolism—BCHE—peripheral nervous system neoplasm	9.02e-06	0.00244	CbGpPWpGaD
Furosemide—PGD—Metabolism—SLC2A1—peripheral nervous system neoplasm	8.89e-06	0.00241	CbGpPWpGaD
Furosemide—PGD—Metabolism—TH—peripheral nervous system neoplasm	8.76e-06	0.00237	CbGpPWpGaD
Furosemide—SLC22A5—Transmembrane transport of small molecules—SLC2A1—peripheral nervous system neoplasm	8.71e-06	0.00236	CbGpPWpGaD
Furosemide—CA7—Metabolism—SLC2A1—peripheral nervous system neoplasm	8.6e-06	0.00233	CbGpPWpGaD
Furosemide—CA5B—Metabolism—SLC2A1—peripheral nervous system neoplasm	8.6e-06	0.00233	CbGpPWpGaD
Furosemide—CA7—Metabolism—TH—peripheral nervous system neoplasm	8.48e-06	0.0023	CbGpPWpGaD
Furosemide—CA5B—Metabolism—TH—peripheral nervous system neoplasm	8.48e-06	0.0023	CbGpPWpGaD
Furosemide—CA12—Metabolism—BCHE—peripheral nervous system neoplasm	8.35e-06	0.00226	CbGpPWpGaD
Furosemide—SLC22A11—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	8.31e-06	0.00225	CbGpPWpGaD
Furosemide—SLC22A11—Transmembrane transport of small molecules—ABCB1—peripheral nervous system neoplasm	8.16e-06	0.00221	CbGpPWpGaD
Furosemide—CA12—Metabolism—SLC2A1—peripheral nervous system neoplasm	7.97e-06	0.00216	CbGpPWpGaD
Furosemide—CA4—Metabolism—ENO2—peripheral nervous system neoplasm	7.88e-06	0.00214	CbGpPWpGaD
Furosemide—SLC22A8—Transmembrane transport of small molecules—SLC2A1—peripheral nervous system neoplasm	7.88e-06	0.00214	CbGpPWpGaD
Furosemide—CA12—Metabolism—TH—peripheral nervous system neoplasm	7.85e-06	0.00213	CbGpPWpGaD
Furosemide—CA2—cerebellum—peripheral nervous system neoplasm	7.69e-06	0.0118	CbGeAlD
Furosemide—CA14—Metabolism—GNAS—peripheral nervous system neoplasm	7.61e-06	0.00206	CbGpPWpGaD
Furosemide—SLC22A5—cerebellum—peripheral nervous system neoplasm	7.57e-06	0.0116	CbGeAlD
Furosemide—CA2—Metabolism—ENO2—peripheral nervous system neoplasm	7.56e-06	0.00205	CbGpPWpGaD
Furosemide—CA14—Metabolism—ABCB1—peripheral nervous system neoplasm	7.46e-06	0.00202	CbGpPWpGaD
Furosemide—CA6—Metabolism—GNAS—peripheral nervous system neoplasm	7.41e-06	0.00201	CbGpPWpGaD
Furosemide—CA5A—Metabolism—GNAS—peripheral nervous system neoplasm	7.41e-06	0.00201	CbGpPWpGaD
Furosemide—CA5A—Metabolism—ABCB1—peripheral nervous system neoplasm	7.27e-06	0.00197	CbGpPWpGaD
Furosemide—CA6—Metabolism—ABCB1—peripheral nervous system neoplasm	7.27e-06	0.00197	CbGpPWpGaD
Furosemide—CA1—Metabolism—ENO2—peripheral nervous system neoplasm	7.25e-06	0.00196	CbGpPWpGaD
Furosemide—PGD—Metabolism—GNAS—peripheral nervous system neoplasm	7.15e-06	0.00194	CbGpPWpGaD
Furosemide—ALB—Platelet activation, signaling and aggregation—KNG1—peripheral nervous system neoplasm	7.05e-06	0.00191	CbGpPWpGaD
Furosemide—PGD—Metabolism—ABCB1—peripheral nervous system neoplasm	7.02e-06	0.0019	CbGpPWpGaD
Furosemide—SLC22A5—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	7.01e-06	0.0019	CbGpPWpGaD
Furosemide—CA5B—Metabolism—GNAS—peripheral nervous system neoplasm	6.92e-06	0.00187	CbGpPWpGaD
Furosemide—CA7—Metabolism—GNAS—peripheral nervous system neoplasm	6.92e-06	0.00187	CbGpPWpGaD
Furosemide—SLC22A5—Transmembrane transport of small molecules—ABCB1—peripheral nervous system neoplasm	6.88e-06	0.00186	CbGpPWpGaD
Furosemide—CA7—Metabolism—ABCB1—peripheral nervous system neoplasm	6.79e-06	0.00184	CbGpPWpGaD
Furosemide—CA5B—Metabolism—ABCB1—peripheral nervous system neoplasm	6.79e-06	0.00184	CbGpPWpGaD
Furosemide—ALB—SLC-mediated transmembrane transport—SLC2A1—peripheral nervous system neoplasm	6.73e-06	0.00182	CbGpPWpGaD
Furosemide—ALB—Metabolism—PPIP5K2—peripheral nervous system neoplasm	6.71e-06	0.00182	CbGpPWpGaD
Furosemide—CA4—Metabolism—BCHE—peripheral nervous system neoplasm	6.66e-06	0.0018	CbGpPWpGaD
Furosemide—SLC22A6—Transmembrane transport of small molecules—SLC2A1—peripheral nervous system neoplasm	6.58e-06	0.00178	CbGpPWpGaD
Furosemide—ALB—Transmembrane transport of small molecules—COX2—peripheral nervous system neoplasm	6.46e-06	0.00175	CbGpPWpGaD
Furosemide—CA12—Metabolism—GNAS—peripheral nervous system neoplasm	6.41e-06	0.00174	CbGpPWpGaD
Furosemide—CA2—Metabolism—BCHE—peripheral nervous system neoplasm	6.39e-06	0.00173	CbGpPWpGaD
Furosemide—ABCC2—Transmembrane transport of small molecules—SLC2A1—peripheral nervous system neoplasm	6.37e-06	0.00173	CbGpPWpGaD
Furosemide—CA9—Metabolism—ENO2—peripheral nervous system neoplasm	6.37e-06	0.00173	CbGpPWpGaD
Furosemide—CA4—Metabolism—SLC2A1—peripheral nervous system neoplasm	6.35e-06	0.00172	CbGpPWpGaD
Furosemide—SLC22A8—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	6.34e-06	0.00172	CbGpPWpGaD
Furosemide—CA12—Metabolism—ABCB1—peripheral nervous system neoplasm	6.29e-06	0.0017	CbGpPWpGaD
Furosemide—CA4—Metabolism—TH—peripheral nervous system neoplasm	6.26e-06	0.0017	CbGpPWpGaD
Furosemide—SLC22A8—Transmembrane transport of small molecules—ABCB1—peripheral nervous system neoplasm	6.22e-06	0.00169	CbGpPWpGaD
Furosemide—CA1—Metabolism—BCHE—peripheral nervous system neoplasm	6.12e-06	0.00166	CbGpPWpGaD
Furosemide—CA2—Metabolism—SLC2A1—peripheral nervous system neoplasm	6.09e-06	0.00165	CbGpPWpGaD
Furosemide—ALB—FOXA2 and FOXA3 transcription factor networks—AKT1—peripheral nervous system neoplasm	6.05e-06	0.00164	CbGpPWpGaD
Furosemide—CA2—Metabolism—TH—peripheral nervous system neoplasm	6e-06	0.00163	CbGpPWpGaD
Furosemide—PGD—Disease—PTPN11—peripheral nervous system neoplasm	5.93e-06	0.00161	CbGpPWpGaD
Furosemide—ALB—Platelet activation, signaling and aggregation—HGF—peripheral nervous system neoplasm	5.87e-06	0.00159	CbGpPWpGaD
Furosemide—CA1—Metabolism—SLC2A1—peripheral nervous system neoplasm	5.84e-06	0.00158	CbGpPWpGaD
Furosemide—CA1—Metabolism—TH—peripheral nervous system neoplasm	5.76e-06	0.00156	CbGpPWpGaD
Furosemide—CA9—Cellular responses to stress—TP53—peripheral nervous system neoplasm	5.48e-06	0.00148	CbGpPWpGaD
Furosemide—CA9—Metabolism—BCHE—peripheral nervous system neoplasm	5.38e-06	0.00146	CbGpPWpGaD
Furosemide—SLC22A6—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	5.29e-06	0.00143	CbGpPWpGaD
Furosemide—SLC22A6—Transmembrane transport of small molecules—ABCB1—peripheral nervous system neoplasm	5.19e-06	0.00141	CbGpPWpGaD
Furosemide—ALB—Folate Metabolism—TP53—peripheral nervous system neoplasm	5.18e-06	0.0014	CbGpPWpGaD
Furosemide—CA9—Metabolism—SLC2A1—peripheral nervous system neoplasm	5.13e-06	0.00139	CbGpPWpGaD
Furosemide—ABCC2—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	5.13e-06	0.00139	CbGpPWpGaD
Furosemide—CA4—Metabolism—GNAS—peripheral nervous system neoplasm	5.11e-06	0.00139	CbGpPWpGaD
Furosemide—CA9—Metabolism—TH—peripheral nervous system neoplasm	5.06e-06	0.00137	CbGpPWpGaD
Furosemide—ABCC2—Transmembrane transport of small molecules—ABCB1—peripheral nervous system neoplasm	5.03e-06	0.00136	CbGpPWpGaD
Furosemide—CA4—Metabolism—ABCB1—peripheral nervous system neoplasm	5.02e-06	0.00136	CbGpPWpGaD
Furosemide—CA2—Metabolism—GNAS—peripheral nervous system neoplasm	4.9e-06	0.00133	CbGpPWpGaD
Furosemide—CA2—Metabolism—ABCB1—peripheral nervous system neoplasm	4.81e-06	0.0013	CbGpPWpGaD
Furosemide—CA1—Metabolism—GNAS—peripheral nervous system neoplasm	4.7e-06	0.00127	CbGpPWpGaD
Furosemide—PGD—Disease—ERBB2—peripheral nervous system neoplasm	4.69e-06	0.00127	CbGpPWpGaD
Furosemide—CA1—Metabolism—ABCB1—peripheral nervous system neoplasm	4.61e-06	0.00125	CbGpPWpGaD
Furosemide—ALB—Metabolism—HSD17B12—peripheral nervous system neoplasm	4.53e-06	0.00123	CbGpPWpGaD
Furosemide—CA9—Metabolism—GNAS—peripheral nervous system neoplasm	4.13e-06	0.00112	CbGpPWpGaD
Furosemide—CA9—Metabolism—ABCB1—peripheral nervous system neoplasm	4.05e-06	0.0011	CbGpPWpGaD
Furosemide—ALB—Hemostasis—IFNB1—peripheral nervous system neoplasm	3.92e-06	0.00106	CbGpPWpGaD
Furosemide—ALB—Metabolism of lipids and lipoproteins—BCHE—peripheral nervous system neoplasm	3.77e-06	0.00102	CbGpPWpGaD
Furosemide—ALB—Hemostasis—KNG1—peripheral nervous system neoplasm	3.63e-06	0.000985	CbGpPWpGaD
Furosemide—PGD—Disease—NRAS—peripheral nervous system neoplasm	3.57e-06	0.000967	CbGpPWpGaD
Furosemide—ALB—Transmembrane transport of small molecules—SLC2A1—peripheral nervous system neoplasm	3.42e-06	0.000926	CbGpPWpGaD
Furosemide—PGD—Disease—MYC—peripheral nervous system neoplasm	3.32e-06	0.000901	CbGpPWpGaD
Furosemide—ALB—Metabolism—GNS—peripheral nervous system neoplasm	3.28e-06	0.000888	CbGpPWpGaD
Furosemide—ALB—Hemostasis—GNAS—peripheral nervous system neoplasm	3.18e-06	0.000861	CbGpPWpGaD
Furosemide—ALB—Metabolism—NME1—peripheral nervous system neoplasm	3.14e-06	0.000852	CbGpPWpGaD
Furosemide—ALB—Hemostasis—HGF—peripheral nervous system neoplasm	3.03e-06	0.00082	CbGpPWpGaD
Furosemide—ALB—Metabolism—COX2—peripheral nervous system neoplasm	3.03e-06	0.00082	CbGpPWpGaD
Furosemide—ALB—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	2.75e-06	0.000745	CbGpPWpGaD
Furosemide—ALB—Transmembrane transport of small molecules—ABCB1—peripheral nervous system neoplasm	2.7e-06	0.000731	CbGpPWpGaD
Furosemide—PGD—Disease—HRAS—peripheral nervous system neoplasm	2.61e-06	0.000707	CbGpPWpGaD
Furosemide—PGD—Disease—AKT1—peripheral nervous system neoplasm	2.3e-06	0.000624	CbGpPWpGaD
Furosemide—ALB—Hemostasis—PTPN11—peripheral nervous system neoplasm	2.21e-06	0.000598	CbGpPWpGaD
Furosemide—CA14—Metabolism—AKT1—peripheral nervous system neoplasm	2.05e-06	0.000556	CbGpPWpGaD
Furosemide—CA5A—Metabolism—AKT1—peripheral nervous system neoplasm	2e-06	0.000542	CbGpPWpGaD
Furosemide—CA6—Metabolism—AKT1—peripheral nervous system neoplasm	2e-06	0.000542	CbGpPWpGaD
Furosemide—ALB—Metabolism—ENO2—peripheral nervous system neoplasm	1.99e-06	0.000538	CbGpPWpGaD
Furosemide—PGD—Metabolism—AKT1—peripheral nervous system neoplasm	1.93e-06	0.000523	CbGpPWpGaD
Furosemide—CA5B—Metabolism—AKT1—peripheral nervous system neoplasm	1.87e-06	0.000506	CbGpPWpGaD
Furosemide—CA7—Metabolism—AKT1—peripheral nervous system neoplasm	1.87e-06	0.000506	CbGpPWpGaD
Furosemide—CA12—Metabolism—AKT1—peripheral nervous system neoplasm	1.73e-06	0.000469	CbGpPWpGaD
Furosemide—ALB—Metabolism—BCHE—peripheral nervous system neoplasm	1.68e-06	0.000455	CbGpPWpGaD
Furosemide—ALB—Platelet activation, signaling and aggregation—AKT1—peripheral nervous system neoplasm	1.66e-06	0.000451	CbGpPWpGaD
Furosemide—ALB—Metabolism—SLC2A1—peripheral nervous system neoplasm	1.6e-06	0.000434	CbGpPWpGaD
Furosemide—ALB—Metabolism—TH—peripheral nervous system neoplasm	1.58e-06	0.000428	CbGpPWpGaD
Furosemide—CA4—Metabolism—AKT1—peripheral nervous system neoplasm	1.38e-06	0.000374	CbGpPWpGaD
Furosemide—ALB—Hemostasis—NRAS—peripheral nervous system neoplasm	1.33e-06	0.00036	CbGpPWpGaD
Furosemide—CA2—Metabolism—AKT1—peripheral nervous system neoplasm	1.32e-06	0.000358	CbGpPWpGaD
Furosemide—ALB—Metabolism—GNAS—peripheral nervous system neoplasm	1.29e-06	0.000349	CbGpPWpGaD
Furosemide—CA1—Metabolism—AKT1—peripheral nervous system neoplasm	1.27e-06	0.000344	CbGpPWpGaD
Furosemide—ALB—Metabolism—ABCB1—peripheral nervous system neoplasm	1.26e-06	0.000343	CbGpPWpGaD
Furosemide—CA9—Metabolism—AKT1—peripheral nervous system neoplasm	1.12e-06	0.000302	CbGpPWpGaD
Furosemide—ALB—Hemostasis—TP53—peripheral nervous system neoplasm	1.02e-06	0.000275	CbGpPWpGaD
Furosemide—ALB—Hemostasis—HRAS—peripheral nervous system neoplasm	9.71e-07	0.000263	CbGpPWpGaD
Furosemide—ALB—Hemostasis—AKT1—peripheral nervous system neoplasm	8.58e-07	0.000232	CbGpPWpGaD
Furosemide—ALB—Metabolism—AKT1—peripheral nervous system neoplasm	3.48e-07	9.42e-05	CbGpPWpGaD
